Effect of low- and high-linear energy transfer radiation on in vitro and orthotopic in vivo models of osteosarcoma by activation of caspase-3 and -9

Int J Oncol. 2017 Oct;51(4):1124-1134. doi: 10.3892/ijo.2017.4102. Epub 2017 Aug 25.

Abstract

Osteosarcoma (OS) is a malignant tumor of the bone derived from primitive transformed cells of the mesenchymal origin. Local low-linear energy transfer (LET) radiotherapy has limited benefits on OS owing to its radioresistance. Thus, this study aimed to investigate the effects of high-LET radiation on human OS. Therefore, the human OS cell lines, U2O2 and KHOS/NP, were examined in vitro, or an orthotopic mouse xenograft model was studied in vivo after treatment with low-LET (gamma-ray) and high-LET (neutron) radiation. Notably, OS cells were significantly more sensitive to high-LET radiation in vitro and in the orthotopic xenograft tumor model. Specifically, neutron radiation treatment increased the relative percentage of apoptotic sub-G1 phase cells via caspase-3/9 activation; increased intracellular reactive oxygen species, autophagy, and DNA damage; and decreased invasion and migration. Similarly, the mean size of gamma-irradiated (8 Gy) orthotopic KHOS/NP OS was 195 mm3 at 6 weeks after gamma-irradiation (8 Gy), but it was only 150 mm3 in mice treated with high-LET neutron radiotherapy. Significantly, our results provide a rationale for the use of high-LET radiotherapy to treat patients with OS.

MeSH terms

  • Animals
  • Apoptosis / radiation effects
  • Bone Neoplasms / enzymology
  • Bone Neoplasms / genetics
  • Bone Neoplasms / pathology
  • Bone Neoplasms / radiotherapy*
  • Caspase 3 / metabolism*
  • Caspase 9 / metabolism*
  • Cell Cycle / radiation effects
  • Cell Line, Tumor
  • Cell Movement / radiation effects
  • DNA Damage
  • Enzyme Activation / radiation effects
  • Female
  • Gamma Rays / therapeutic use
  • Humans
  • Linear Energy Transfer
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neutrons / therapeutic use
  • Osteosarcoma / enzymology
  • Osteosarcoma / genetics
  • Osteosarcoma / pathology
  • Osteosarcoma / radiotherapy*
  • Random Allocation
  • Xenograft Model Antitumor Assays

Substances

  • Caspase 3
  • Caspase 9